Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (161-170 of 270) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|August 31, 2023
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19Mark J Giganti, Kara W Chew, Joseph J Eron, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Pathogens & Immunity|August 21, 2024
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody TreatmentUrvi M Parikh, Amy L Heaps, Daniela Moisi, et al.
Lab on a Chip|October 20, 2025
A luminescence-based point-of-care HIV viral load test for antiretroviral therapy monitoringSungwan Kim, Hak-Rae Hong, Jong-Min Oh, et al.
The Journal of Infectious Diseases|August 26, 2017
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for MalignancyTimothy J Henrich, Kristen S Hobbs, Emily Hanhauser, et al.
Elife|March 11, 2022
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infectionNoah J Silverstein, Yetao Wang, Zachary Manickas-Hill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019Yijia Li, Linda J Harrison, Kara W Chew, et al.
Nature Communications|June 30, 2021
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIVLeila B Giron, Clovis S Palmer, Qin Liu, et al.
The Journal of Infectious Diseases|July 22, 2021
Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?Lydia L Shook, Evan A Bordt, Marie-Charlotte Meinsohn, et al.
Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
Pageof 27

Showing results (161-170 of 270) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|August 31, 2023
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19Mark J Giganti, Kara W Chew, Joseph J Eron, et al.
The Journal of Infectious Diseases|June 5, 2020
Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral TherapyNikolaus Jilg, Pilar Garcia-Broncano, Michael Peluso, et al.
Pathogens & Immunity|August 21, 2024
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody TreatmentUrvi M Parikh, Amy L Heaps, Daniela Moisi, et al.
Lab on a Chip|October 20, 2025
A luminescence-based point-of-care HIV viral load test for antiretroviral therapy monitoringSungwan Kim, Hak-Rae Hong, Jong-Min Oh, et al.
The Journal of Infectious Diseases|August 26, 2017
Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for MalignancyTimothy J Henrich, Kristen S Hobbs, Emily Hanhauser, et al.
Elife|March 11, 2022
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infectionNoah J Silverstein, Yetao Wang, Zachary Manickas-Hill, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2022
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019Yijia Li, Linda J Harrison, Kara W Chew, et al.
Nature Communications|June 30, 2021
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIVLeila B Giron, Clovis S Palmer, Qin Liu, et al.
The Journal of Infectious Diseases|July 22, 2021
Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?Lydia L Shook, Evan A Bordt, Marie-Charlotte Meinsohn, et al.
Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
Pageof 27